Last reviewed · How we verify
Hypertension as add-on therapy
Approved treatments
- Aldactone · Pfizer Inc.
Aldosterone antagonist causing increased sodium and water excretion while retaining potassium.
Clinical guidelines
- FDA label — 2L
Spironolactone is indicated as add-on therapy for the treatment of hypertension, to lower blood pressure in patients who are not adequately controlled on other agents. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hypertension as add-on therapy patent landscape — cliff calendar, originator estates, attackable patents
- Hypertension as add-on therapy treatment landscape brief
- Hypertension as add-on therapy treatment updates RSS
Frequently asked questions about Hypertension as add-on therapy
What drugs treat Hypertension as add-on therapy?
Tracked treatments include Aldactone.
What is the treatment for Hypertension as add-on therapy?
Standard treatment for Hypertension as add-on therapy includes Aldactone. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Hypertension as add-on therapy?
FDA label publishes guidelines for Hypertension as add-on therapy. 1 guideline references tracked.
Related
- Treatment landscape: Hypertension as add-on therapy patent cliff · Hypertension as add-on therapy CI report
- Treatment: Aldactone · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing